H1 2024 revenue dipped 1.34% year-over-year, but net profit rose 7.89% as probiotics and animal/plant microecological products drove growth, offsetting a decline in food additives. R&D investment and new capacity support future expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.